Progressive Health Innovations Announces Issuance of US Patent

Share Article

Progressive Health Innovations Inc. (PHI) is pleased to announce that the US Patent office has awarded Patent # 7,794,367 for its flagship product, the AFX (Ankle Foot maXimizer),

The issuance of the patent in the US and elsewhere strengthens PHI’s position as a true innovator and leader in the field of foot and ankle strengthening.”

Progressive Health Innovations Inc. (PHI) is pleased to announce that the US Patent office has awarded Patent # 7,794,367 for its flagship product, the AFX (Ankle Foot maXimizer),

PHI is the first company to provide a uniquely designed Class 1 medical device that allows for complete foot and ankle strengthening. The patent covers the technology of PHI’s AFX, which includes:

  • Innovative Resistance System: allows for balanced strengthening and can be used by practitioners performing post-surgical rehab through to athletes looking to increase their performance.
  • Flexible Foot Support: enables the user to arch or extend the foot and toes, strengthen intrinsic muscles, and ensures proper anatomical alignment of resistance regardless of foot length.
  • Functional Strengthening: AFX’s unique design allows the user to mirror movement patterns that are specific to their sport or activity.

“We are very pleased to have achieved this exciting milestone in expanding our intellectual property portfolio, and in increasing value for our shareholders,” states Matt Ferguson, President and CEO of PHI. “The issuance of the patent in the US and elsewhere strengthens PHI’s position as a true innovator and leader in the field of foot and ankle strengthening.”

For More Information Contact:
Matt Ferguson
President & CEO
Progressive Health Innovations Inc.
Ph. 604.644.9971

About Progressive Health Innovations Inc.
Product Site: http://www.AFX-Online.com
Company Site: http://www.ProgressiveHealth.ca
Progressive Health Innovations Inc. (PHI), is a privately held health technology company that develops user-friendly and affordable products for the rehabilitation, sports medicine, athletic performance and fitness markets. The first product line to be launched will be the Ankle Foot maXimizer (AFX), a foot and ankle-strengthening technology targeted at the rehabilitation and athletic training markets.

Certain information contained in this press release may be forward-looking and is subject to unknown risks, which could cause actual results to differ materially from those set forth or implied herein. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove correct.

###

Share article on social media or email:

View article via:

Pdf Print